Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Bariatric surgery is associated with a significantly greater long-term weight loss than treatment with GLP-1 receptor agonists, a new head-to-head real-world study finds.

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

The companies are working together to make it easier for companies to offer health plans that include these medications.

At the same time, and likely because of this, data shows that demand for bariatric surgery has plunged, dropping nearly 26 ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...